Concepedia

Siglinde Wolf

SW

Statistics

Publications

11

Citations

842

H-Index

11

Active since

2009

Affiliations

Max Planck Institute of Biochemistry(Current)

University of Pittsburgh

University of Groningen

Jagiellonian University

Max Planck Society

Siglinde Wolf is an author at Max Planck Institute of Biochemistry specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2009–2014

11

Publications

11

Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery

Grzegorz M. Popowicz, Anna Czarna, Siglinde Wolf et al. · Cell Cycle · 2010 · 229 citations

, , +8

Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists

Anna Czarna, Barbara Beck, Stuti Srivastava et al. · Angewandte Chemie International Edition · 2010 · 134 citations · Full text

, , +17

Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists

David Ryan Koes, Kareem Khoury, Yijun Huang et al. · PLoS ONE · 2012 · 103 citations · Full text

, , +11

High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx

Anna Czarna, Grzegorz M. Popowicz, Aleksandra Pęcak et al. · Cell Cycle · 2009 · 99 citations · Full text

, , +16

1,4‐Thienodiazepine‐2,5‐diones via MCR (I): Synthesis, Virtual Space and p53‐Mdm2 Activity

Yijun Huang, Siglinde Wolf, Michał Biśta et al. · Chemical Biology & Drug Design · 2010 · 64 citations · Full text

, , +17

1–5 of 11